Report Library
View More
Datamonitor Healthcare CV&Met Disea...
November 18, 2022
Datamonitor Healthcare Oncology: Ac...
November 18, 2022
Datamonitor Healthcare Other: Hypog...
November 18, 2022
Datamonitor Healthcare Oncology: My...
November 18, 2022
Datamonitor Healthcare Oncology Dis...
November 17, 2022
Datamonitor Healthcare CV&Met Disea...
November 17, 2022
Datamonitor Healthcare CV&Met Disea...
November 17, 2022
Datamonitor Healthcare Oncology Dis...
November 16, 2022
Datamonitor Healthcare Respiratory:...
November 16, 2022
Datamonitor Healthcare Oncology: Gl...
November 16, 2022
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 11/22/22 | Merck (MRK) | Keytruda for Gastric Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 11/17/22 | Astellas Pharma (4503:JP) | Zolbetuximab for Gastric Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 11/16/22 | Mineralys | MLS-101 for Hypertension (Systemic) | Subscribers Only | Subscribers Only | Subscribers Only |
| 11/16/22 | Ardelyx (ARDX) | XPHOZAH for Hyperphosphatemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 11/15/22 | Arcutis (ARQT) | Zoryve for Atopic Dermatitis (Eczema) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 11/29/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| Now - 11/30/22 | Subscribers Only | Subscribers Only | Regulatory - CHMP (European Panel) Results |
| Now - 11/30/22 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Approval (Japan) |
| Now - 11/30/22 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| Now - 11/30/22 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation (Emerging Markets) |
